Short Interest in Carl Zeiss Meditec AG (OTCMKTS:CZMWY) Declines By 89.4%

Carl Zeiss Meditec AG (OTCMKTS:CZMWY) saw a significant decrease in short interest in August. As of August 14th, there was short interest totaling 19 shares, a decrease of 89.4% from the July 30th total of 180 shares. Based on an average daily volume of 4,928 shares, the short-interest ratio is currently 0.0 days.

Carl Zeiss Meditec Trading Down 1.0%

CZMWY opened at $37.33 on Wednesday. The firm’s fifty day moving average is $33.47 and its two-hundred day moving average is $31.30. Carl Zeiss Meditec has a twelve month low of $26.65 and a twelve month high of $55.94.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on the stock. Zacks Research lowered shares of Carl Zeiss Meditec from a “hold” rating to a “strong sell” rating in a report on Tuesday, August 11th. UBS Group downgraded Carl Zeiss Meditec from a “neutral” rating to a “sell” rating in a report on Tuesday, August 11th. One research analyst has rated the stock with a Buy rating, two have given a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Reduce”.

Carl Zeiss Meditec Company Profile

Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.

The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.